Palisade Bio
PALI
5 hedge funds and large institutions have $5.14M invested in Palisade Bio in 2017 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, reducing their positions, and 3 closing their positions.
16% more call options, than puts
Call options by funds: $2.9M | Put options by funds: $2.5M
0% less ownership
Funds ownership: 0% → 0% (-0%)
29% less funds holding
Funds holding: 7 → 5 (-2)
35% less capital invested
Capital invested by funds: $7.85M → $5.14M (-$2.71M)
67% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
William Blair & Company
Chicago,
Illinois
|
+$439K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$2.63M |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$439K |
| 3 |
VKH
Virtu KCG Holdings
New York
|
-$439K |
| 4 |
Millennium Management
New York
|
-$62K |
| 5 |
PNC Financial Services Group
Pittsburgh,
Pennsylvania
|
-$28K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
26
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$439K | -1 | Closed |
|
|
DC
27
Davenport & Co
Richmond,
Virginia
| – | -$6.56K | – | – |
|
|
FSCM
28
Front Street Capital Management
Missoula,
Montana
| – | -$3K | – | – |
|
|
29
Millennium Management
New York
| – | -$62K | – | – |
|
|
30
PNC Financial Services Group
Pittsburgh,
Pennsylvania
| – | -$28K | – | – |
|
PALI Hedge Fund Activity: Q2 2017 in Review
5 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Palisade Bio (PALI) for Q2 2017, worth a combined $5.14M — down 35% from $7.85M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of PALI and 1 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 0 added.
The largest buyer was William Blair & Company, opening a new position worth an estimated $439K. The largest seller was Sabby Management, exiting entirely with an estimated $2.63M sold.
- 5 institutional investors held Palisade Bio (PALI) as of Q2 2017, down from 7 in Q1 2017.
- Funds reported $5.14M of Palisade Bio stock for Q2 2017, down 35% quarter-over-quarter.
- 1 fund opened new Palisade Bio positions in Q2 2017 and 3 closed out, a net change of -2 holders.
- The largest Palisade Bio buyer in Q2 2017 was William Blair & Company, an estimated $439K added.
- The largest Palisade Bio seller in Q2 2017 was Sabby Management, an estimated $2.63M sold.
Based on aggregated 13F filings for Q2 2017.